Shringar House of Mangalsutra IPO 2025: 10 Powerful Insights on GMP, Dates, Price Band & Allotment

Shringar House of Mangalsutra

tredingmarket.com

shringar.ms

Shringar House of Mangalsutra Ltd IPO is one of the most anticipated jewelry sector offerings in 2025, aiming to raise ₹400.95 crore entirely through a fresh issue of 2.43 crore equity shares. The IPO is open for subscription between September 10 and September 12, 2025, with the basis of allotment expected on September 15, 2025, and listing scheduled on both the NSE and BSE by September 17, 2025.

The IPO price band has been fixed at ₹155–₹165 per share, with a lot size of 90 shares, making the minimum retail application value ₹14,850 at the upper band. For small non-institutional investors (sNII), the minimum investment is ₹2,07,900 (1,260 shares), while large non-institutional investors (bNII) must apply with at least ₹10,09,800 (6,120 shares). The company has also offered a ₹15 per share discount to employees.

On September 9, 2025, ahead of the IPO opening, the company successfully raised ₹120.19 crore through anchor investors by issuing 72.84 lakh shares. This round attracted marquee participants including Kotak Mahindra Life Insurance, Societe Generale, Aidos India Fund, Nav Capital VCC, and Founders Collective Fund, reflecting strong institutional confidence.

In terms of reservation, the IPO has earmarked 49.96% for QIBs (of which 29.98% is for anchor investors), 14.99% for NIIs, 34.97% for retail investors, and a small 0.08% for employees. This structured allocation ensures participation from all categories of investors.

The company, founded in 2009, is a niche player focused on the design, manufacture, and sale of mangalsutras—an essential and culturally significant piece of jewelry in India. It offers thousands of designs using 18K and 22K gold, embellished with American diamonds, cubic zirconia, pearls, and semi-precious stones. Shringar operates both domestically and internationally, supplying to 24 Indian states and 4 union territories, and exporting to countries such as the UAE, USA, UK, Fiji, and New Zealand. Its key B2B clients include renowned names like Titan Company, Malabar Gold, GRT Jewellers, Joyalukkas, Reliance Retail, and Damas Jewellery (UAE).

Over the past three financial years, the company has shown impressive growth. Revenue rose from ₹951.29 crore in FY2023 to ₹1,102.71 crore in FY2024, and further to ₹1,430.12 crore in FY2025. Profit after tax almost doubled in the latest fiscal, jumping from ₹31.11 crore in FY2024 to ₹61.11 crore in FY2025. Its EBITDA margin improved to 6.48%, while the PAT margin reached 4.27%. With a Return on Equity (RoE) of 36.2% and Return on Capital Employed (RoCE) of 32.43%, the company demonstrates strong profitability.

At the IPO price band, Shringar House of Mangalsutra is valued at a post-issue P/E multiple of ~26.04× and a price-to-book value of ~5.93×, translating into a market capitalization of approximately ₹1,591 crore. While the valuation is slightly on the higher side compared to some listed peers like RBZ Jewellers (P/E ~14.5×) and Sky Gold (P/E ~31.5×), analysts believe the company’s unique positioning in the mangalsutra category, established client base, and expanding exports justify the premium.

The company intends to utilize ₹280 crore from the IPO proceeds for working capital requirements, with the remainder earmarked for general corporate purposes. This capital infusion will help the company manage its bullion procurement, scale its production capacity, and strengthen its export networks.

Investor enthusiasm for the IPO has been evident from the beginning. On Day 1, the issue was fully subscribed, with strong retail demand pushing subscription levels higher. By Day 2, the IPO was oversubscribed 8.24×, and on the final day (Day 3), the subscription soared to nearly 29.72× overall, with Retail 99.6×, NII 39×, and QIB 2.45×. In the grey market, the IPO maintained a GMP of ₹34 (~20% premium), signaling expectations of healthy listing gains.

Competitive strengths include an established domestic and international client base, an integrated design and manufacturing facility, continuous innovation, a large and diverse SKU portfolio, stringent quality control, and a professional management team led by experienced promoters.

Key risks, however, include the company’s reliance on a single jewelry category (mangalsutras), exposure to fluctuations in gold and diamond prices, high working capital requirements, and the relatively expensive valuation. Investors should also note that being a B2B-focused jewelry manufacturer, its fortunes are tied closely to demand from large retail clients and the broader wedding and cultural jewelry markets.

Industry experts highlight that the Indian mangalsutra market is valued at approximately ₹303 billion and is poised for steady growth due to cultural significance, rising disposable incomes, and increasing branded jewelry penetration. Shringar, being one of the few organized players dedicated to this niche, stands well-positioned to capture this opportunity.

Given the strong fundamentals, robust financial performance, established client base, and overwhelming investor interest, analysts broadly recommend a “Subscribe” rating—especially for investors with a medium-to-long-term horizon. While short-term listing gains appear likely given the strong GMP and oversubscription levels, long-term investors can benefit from the company’s growth trajectory and sectoral tailwinds.

Essential IPO Snapshot & Timeline

DetailSpecification
Issue Type100% Fresh Issue (Book-Built)
Size₹400.95 cr (2.43 crore shares)
Price Band₹155 to ₹165
Lot Size90 shares
Retail Min Investment₹14,850 (1 lot)
Retail Max Investment~₹1.93 lakh (13 lots)
ReservationsRetail: 35%, NII: 15%, QIB: ≤50% with Anchor participation
Anchor Allotment Date9 September 2025
Bid Period10–12 September 2025
Allotment Date15 September (Tentative)
Demat/Refund16 September
Listing Date17 September 2025 (Tentative)
Lead ManagerChoice Capital Advisors Pvt. Ltd.
RegistrarMUFG Intime India Pvt. Ltd.

3. Anchor Investor Round

On 9 September, before the public bid opened, the IPO secured ₹120 crore from anchor investors through allocation of 72.84 lakh shares at ₹165 each—offering confidence from marquee names like Kotak Mahindra Life, Societe Generale, AIDOS India Fund, Nav Capital VCC, and Founders Collective Fund.
The Economic Times


4. Subscription Status & GMP Trend

  • Day 1: Fully subscribed on opening day; Retail demand robust; GMP ~16%
    The Economic Times
  • Day 2: Ended with 8.24× oversubscription; GMP steady at ~16%
    The Economic Times
  • Day 3 (midday): Subscription soared to ~29.72×. Retail: ~99.6×; NIIs: ~39×; QIBs: ~2.45×. GMP jumped to ₹34 (~20.6%), suggesting strong listing gains.
    Business Standard

5. Company Snapshot & Fund Deployment

Founded in 2009, Shringar House of Mangalsutra Ltd specializes in designing, manufacturing, and marketing mangalsutras using 18K and 22K gold, diamonds, CZ, pearls, and semi-precious stones. It serves clients across 24 Indian states, four union territories, and exports to markets like UAE, UK, USA, NZ, and Fiji. Key clients include Titan, Malabar Gold, Joyalukkas, among others.

IPOs Proceeds Allocation:

  • ₹280 crore for working capital
  • Remaining funds for general corporate purposes
    Scribd

6. Financials & Peer Comparison

Metric (₹ crore)FY2023FY2024FY2025
Revenue951.31,102.71,430.1
PAT23.3631.1161.11
EBITDA38.8950.7692.61
Net Worth105.72136.85200.85
Assets211.55265.0375.75
Borrowings93.19110.09123.11

Key Ratios (FY25)

  • EPS (Pre-issue): ₹8.47 → Post-issue Estimate: ₹6.34
  • ROE: 36.2% | ROCE: 32.43% | Debt/Equity: 0.61
    IPO Wala

Valuation Metrics (at ₹165):

Peer Comparison (FY25)

  • Shringar: P/E ~26; EV/EBITDA ~14.2×; EV/Sales ~0.9×
  • RBZ Jewellers: P/E ~14.5×
  • Sky Gold & Diamonds: P/E ~31.5×
    Scribd

7. Strengths & Risks

Strengths

  • Leading niche business in mangalsutra manufacturing
  • Integrated design and manufacturing with 10,000+ SKUs
  • Strong financial growth—PAT doubled between FY24 and FY25
  • Solid working relationship with leading retail chains and exporters

Risks

  • High valuations — heavy premium relative to peers
  • Capital-intensive operations with working capital pressures
  • Limited post-listing liquidity as a mid-cap IPO
  • Dependence on gold prices and cyclical Indian weddings sector
    INDmoney+1

8. Analyst Sentiment

  • Anand Rathi Research recommends “Subscribe for Long-term,” citing structural market growth, solid margins, and efficient new network expansion.
  • BP Equities tags it ‘Subscribe’, noting valuation alignment with peers and scalability upside.
  • Master Capital Services highlights the ₹303 billion growing mangalsutra market and Shringar’s positioning to capture that.
    mint+1

9. FAQs (Google-style)

  1. What are the IPO dates and price?
    Open: 10–12 Sept 2025; Price: ₹155–165/sh.
    The Economic Times
  2. What’s the issue size?
    ₹400.95 cr; 100% fresh issue of 2.43 cr shares.
    IPO Wala
  3. Anchor investors?
    ₹120 cr raised on 9 Sept; 72.84 lakh shares allocated.
    The Economic Times
  4. GMP trend?
    Day 1: 16%; Day 2: 16%; Day 3: ~20.6% (₹34).
    The Economic Times+2The Economic Times+2
  5. Subscription status?
    Day 2: 8.24×; Day 3: ~29.72×.
    The Economic Times+1
  6. How to check allotment?
    Via registrar MUFG Intime’s IPO status portal and exchange websites.
    Upstox – Online Stock and Share Trading
  7. Use of proceeds?
    ₹280 cr for working capital; balance for corporate purposes.
    Scribd
  8. Valuation multiples?
    P/E ~26×; P/B ~5.9×; Market cap ~₹1,591 cr.
    The Economic Times+1
  9. Why subscribe?
    Strong fundamentals, niche leadership, excellent growth trends, buoyant investor sentiment.

10. Important IPO Links (Official Only)


Further reading on this IPO

Conclusion

The Shringar House of Mangalsutra IPO stands out as an attractive jewelry-sector IPO with strong financial momentum, strategic growth engines, and enthusiastic investor response (nearly 30× oversubscription and rising GMP). At P/E ~26×, it commands a premium, but the company’s growth trajectory, brand positioning, and operational efficiency justify a long-term bet. Investors comfortable with IPO volatility and high ticket size may find this issue a compelling structural play—while cautious long-term players should monitor margins, working capital cycle, and post-listing performance before fully deploying capital.

Leave a Comment